| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V98991 | 7030B-C5 | 370871-42-4 | 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM). |
|
V87653 | AZD8233 | 2604215-74-7 | AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis. |
|
V87648 | CVI-LM001 | CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect. | |
|
V1879 | SBC-115076 | 489415-96-5 | SBC-115076 (SBC115076) is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist, with the potentialfor the treatment and/or prevention of cardiovascular diseases. |
|
V145192 | SPC4061 sodium scrambled negative control | The SPC4061 sodium scrambled negative control is a negative control with the sequence of SPC4061 sodium salt scrambled. | |
|
V87645 | SPC5001 sodium | SPC5001 sodium is a locked nucleic acid (LNA) modified antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA. | |
|
V145193 | SPC5001 sodium scrambled negative control | The SPC5001 sodium scrambled negative control is a negative control with the sequence of SPC5001 sodium salt scrambled. | |
|
V145264 | SS(no Galnac)-Inclisiran sodium | SS(no Galnac)-Inclisiran sodium is a single-chain inclisiran that does not contain GalNAc. | |
|
V145269 | SS-Inclisiran sodium | SS-Inclisiran sodium is a mitotic chain of Inclisiran. |